Kaplan–Meier survival curves for all lower-grade glioma and WHO 2016... | Download Scientific Diagram
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text
Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... | Download Scientific Diagram
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery | Acta Neuropathologica Communications | Full Text
Brain Tumour Registry of Canada (BTRC): Survival and Prevalence Report 2010–2017 June 2022
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy | Journal of Cancer Research and Clinical Oncology
Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas | American Journal of Neuroradiology
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis | Anticancer Research
Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates for diffuse astrocytic tumors in adults. Working toward the extended use of MRI data in integrated glioma diagnosis - Roux -
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas - ScienceDirect
Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors - ScienceDirect
.jpg "Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery")
Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery
Current therapeutic approaches to diffuse grade II and III gliomas - Alberto Picca, Giulia Berzero, Marc Sanson, 2018
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals
Advantages of gross total resection in patients with astrocytoma: A population‑based study
Astrocytoma Treatment & Management: Approach Considerations, Surgical Care, Medical Care
Predicting overall survival in diffuse glioma from the presurgical connectome | Scientific Reports
Risk factors for early progression of diffuse low-grade glioma in adults | Chinese Neurosurgical Journal
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas | SpringerLink
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram
Survival patterns of oligoastrocytoma patients: A surveillance, epidemiology and end results (SEER) based analysis - ScienceDirect
